Which breathing device helps heart surgery patients breathe easier?

NCT ID NCT04164173

Recruiting now Disease control Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares three breathing therapy devices (EzPAP, Metaneb, and IPPB) to see which one best helps lung recovery after heart surgery. 324 adults who had open-heart surgery will use one of the devices for 10 minutes, four times a day. The goal is to find which therapy improves lung function the most.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Breathing therapy devices (EzPAP, Metaneb, IPPB)
What this could lead to: If successful, this could identify the most effective breathing therapy to help patients recover lung function faster after heart surgery.
What could go wrong: This is a mid-sized trial comparing existing devices, not a new breakthrough. Results may show no clear winner or only modest benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung disorder Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE COMPLICATIONS PULMONARY DISEASE

Contacts and locations

Locations

UT Southwestern Clements University Hospital
RECRUITING

Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.